Chinese patent medicine Bailing capsule for treating lupus nephritis: A protocol for systematic review and meta-analysis

BACKGROUND: Treatment of lupus nephritis (LN) remains challenging. LN remains the primary source of morbidity and mortality in patients with systemic lupus erythematosus. Chinese patent medicine Bailing capsule is commonly used for the treatment of LN. However, there is no consensus on the differenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Hui-Jie, Sun, Ya-Lei, Yuan, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750295/
https://www.ncbi.nlm.nih.gov/pubmed/31517824
http://dx.doi.org/10.1097/MD.0000000000017041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750295/
https://www.ncbi.nlm.nih.gov/pubmed/31517824
http://dx.doi.org/10.1097/MD.0000000000017041

Ejemplares similares